Cytek Biosciences, Inc.
CTKB· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $24.27M | — |
| Net Income | $102.00K | -$839.00K |
| EPS Diluted | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR